Online inquiry

IVTScrip™ mRNA-Human ARPC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25068MR)

This product GTTS-WK25068MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARPC3 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001278556.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10094
UniProt ID O15145
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARPC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25068MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK10778MR IVTScrip™ mRNA-Human AFAP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AFAP1
GTTS-WK25045MR IVTScrip™ mRNA-Human ARL5B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL5B
GTTS-WK14900MR IVTScrip™ mRNA-Human ANKRD13A, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD13A
GTTS-WK9680MR IVTScrip™ mRNA-Human ABLIM3, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ABLIM3
GTTS-WK25026MR IVTScrip™ mRNA-Human ARID4B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARID4B
GTTS-WK20355MR IVTScrip™ mRNA-Human ANTXR1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANTXR1
GTTS-WK18211MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD26P1
GTTS-WK14998MR IVTScrip™ mRNA-Human APBB1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APBB1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW